Diabetes Professional Resources Online  /  American Diabetes Association
Home About Us Donate Now Join ADA
DiabetesPro Home
Meetings and Continuing Education Opportunities
Scientific Sessions Webcasts
Resources for Professionals
Clinical Practice
Recommendations
Professional Membership
Journals
Books for Professionals
Research Grant Applications and Administration
About Diabetes Research
Recognition Programs
Professional Section
Interest Groups
Professional Section
Quarterly
Point of Care
Thomson Reuters - Prous Science
 
Study
Click to add/remove this article to your list of 'My Favorites'
Sibutramine in obesity:The STORM (Sibutramne Trial on Obesity Reduction and Maintenance) study
Patients Obese patients (n=261)
Treatment Regimen Sibutramine, 10 mg/d x 6 mo --> 10-20 mg/d x 18 mo, Sibutramine, 10 mg/d x 6 mo --> Placebo
Conclusions Maintenance therapy with sibutramine after an initial weight-loss phase maintained weight loss better than placebo, especially in patients with higher leisure-time physical activity index
Reference(s) Leisure-time activity is an important determinant of long-term weight maintenance after weight loss in the Sibutramine Trial on Obesity Reduction and Maintenance (STORM trial)
Am J Clin Nutr 2003, 78(2):209
Author and Affiliation Van Baak, M.A., Van Mil, E., Astrup, A.V., et al.
PubMed